Human hantavirus infections: Epidemiology, clinical features, pathogenesis and immunology

Swiss Medical Weekly

Volumn 144, Issue , 2014, Pages

  Manigold, Tobias ^a   Vial, Pablo ^b,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Hantavirus; HCPS; HFRS; Immunology; Pathogenesis

Indexed keywords

METHYLPREDNISOLONE; RIBAVIRIN; STEROID;

ABDOMINAL PAIN; CLINICAL FEATURE; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS; HANTAVIRUS INFECTION; HEADACHE; HEMATURIA; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HYPOTENSION; IMMUNOFLUORESCENCE; IMMUNOLOGY; INTESTINAL BLEEDING; LEUKOCYTOSIS; LEUKOPENIA; MALAISE; MYALGIA; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TACHYCARDIA; THROMBOCYTOPENIA; VIRUS PATHOGENESIS; ANIMAL; HANTAVIRUS PULMONARY SYNDROME;

ANIMALS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS;

EID: 84899736371     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.13937     Document Type: Review

References (85)

1. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis. [Internet]. 1978;137:298-308. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24670.
2. Smadel JE. Epidemic hemorrhagic fever. Am J Public Health Nations Health. [Internet]. 1953 Oct [cited 2013 Oct 13];43(10):1327-30. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1620469&tool= pmcentrez&rendertype=abstract.
3. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. [Internet]. 1997;3:95-104. Available from: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=2627612&tool=pmcentrez&rendertype= abstract.
4. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993;262:914-7. (Pubitemid 24014083)
5. Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Nichol S, Spiropoulou C, et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg. [Internet]. 1995;52:117-23. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=7872437.
6. López N, Padula P, Rossi C, Lázaro ME, Franze- Fernández MT. New hantaviruses causing hantavirus pulmonary syndrome in central Argentina. [Internet]. Virology. 1997;349:998-9. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=9100632.
7. Padula PJ, Colavecchia SB, Martínez VP, Gonzalez Della Valle MO, Edelstein A, Miguel SDL, et al. Genetic Diversity, Distribution, and Serological Features of Hantavirus Infection in Five Countries in South America. J Clin Microbiol. [Internet]. 2000;38:3029-35. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=87178&tool= pmcentrez&rendertype=abstract.
8. Vincent MJ, Quiroz E, Gracia F, Sanchez AJ, Ksiazek TG, Kitsutani PT, et al. Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology. [Internet]. 2000;277:14-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11062031.
9. Krüger DH, Ulrich RG, Hofmann J. Hantaviruses as zoonotic pathogens in Germany. Dtsch Arztebl Int. [Internet]. 2013 Jul [cited 2013 Oct 13];110(27-28):461-7. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3722641&tool=pmcentrez&rendertype=abstract.
10. Hantavirus pulmonary syndrome in visitors to a national park - Yosemite Valley, California, 2012. MMWR Morb Mortal. Wkly Rep [Internet]. 2012 Nov 23 [cited 2013 Oct 13];61(46):952. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/23169317.
11. Puerta H, Cantillo C, Mills J, Hjelle B, Salazar-Bravo J, Mattar S. The New-World Hantaviruses. Ecology and epidemiology of an emerging virus in Latin America. Med Aires. 2006;66:343-56. (Pubitemid 44390052)
12. Máttar S, Parra M. Serologic evidence of hantavirus infection in humans, Colombia. Emerg Infect Dis [Internet]. 2004 Dec [cited 2013 Oct 13];10(12):2263-4. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3323398&tool=pmcentrez&rendertype=abstract.
13. Alemán A, Iguarán H, Puerta H, Cantillo C, Mills J, Ariz W, et al. First serological evidence of Hantavirus infection in rodents in Colombia. Rev Salud Publica Bogota Colomb [Internet]. 2006;8 Suppl 1:1-12. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=16925117.
14. Rosa EST, Mills JN, Padula PJ, Elkhoury MR, Ksiazek TG, Mendes WS, et al. Newly recognized hantaviruses associated with hantavirus pulmonary syndrome in northern Brazil: partial genetic characterization of viruses and serologic implication of likely reservoirs. Vector borne zoonotic Dis Larchmont NY [Internet]. 2005;5:11-9. Available from: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=15815145.
15. Casapía M, Mamani E, García MP, Miraval ML, Valencia P, Quino AH, et al. [Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region]. Rev Peru Med Exp Salud Publica [Internet]. [cited 2013 Oct 13];29(3):390-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 23085803.
16. Kallio ER, Voutilainen L, Vapalahti O, Vaherl A, Henttonen H, Koskela E, et al. Endemic hantavirus infection impairs the winter survival of its rodent host. Ecology. 2007;88:1911-6.
17. Olsson GE, Dalerum F, Hörnfeldt B, Elgh F, Palo TR, Juto P, et al. Human hantavirus infections, Sweden. Emerg Infect Dis. 2003;9:1395-401. (Pubitemid 37356211)
18. Torres-Pérez F, Wilson L, Collinge SK, Harmon H, Ray C, Medina RA, et al. Sin Nombre Virus Infection in Field Workers, Colorado, USA. Emerg Infect Dis [Internet]. 2010;16:308-10. Available from: http://www.cdc.gov/eid/content/ 16/2/308.htm.
19. Merino C, Arias A, Castillo C. First Case of Hantavirus Cardiopulmonary Syndrome Occurring after a Rodent Bite. Rev Chil Enf Respir. 2002;18:199-205.
20. Kallio ER, Klingström J, Gustafsson E, Manni T, Vaheri A, Henttonen H, et al. Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol. 2006;87:2127-34.
21. Jameson LJ, Taori SK, Atkinson B, Levick P, Featherstone C a, van der Burgt G, et al. Pet rats as a source of hantavirus in England and Wales, 2013. Euro Surveill [Internet]. 2013 Jan;18(9):8-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23470018.
22. Taori SK, Jameson LJ, Campbell A, Drew PJ, McCarthy ND, Hart J, et al. UK hantavirus, renal failure, and pet rats. Lancet [Internet]. 2013 Mar 23 [cited 2013 Oct 13];381(9871):1070. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 23668557.
23. Lundkvist A, Verner-Carlsson J, Plyusnina A, Forslund L, Feinstein R PA. Pet rat harbouring Seoul hantavirus in Sweden, June 2013. Euro Surveill [Internet]. 2013 [cited 2013 Oct 13];Jul 4(18(27)):pii: 20521. Available from: http://www.eurosurveillance.org/images/dynamic/EE/V18N27/art20521.pdf.
24. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis [Internet]. 2005;11:1848-53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16485469.
25. Martinez VP, Bellomo CM, Cacace ML, Suarez P, Bogni L, Padula PJ. Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis [Internet]. 2010 Dec [cited 2013 Oct 13];16(12):1853-60. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3294556&tool= pmcentrez&rendertype=abstract.
26. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, et al. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. J Infect Dis [Internet]. 2007;195:1563-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17471425.
27. Castillo C, Villagra E, Sanhueza L, Ferres M, Mardones J, Mertz GJ. Prevalence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile. Am J Trop Med Hyg [Internet]. 2004 Mar;70(3):302-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15031521.
28. Padula PJ, Edelstein A, Miguel SD, López NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology [Internet]. 1998;241:323-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9674243.
29. Martinez-Valdebenito C, Calvo M, Ferres M, Vial C, Mansilla R, Marco C, et al. Andes hantavirus case-cluster with household and first nosocomial transmission in Southern Chile. Submitt Publ.
30. Täger Frey M, Vial PC, Castillo CH, Godoy PM, Hjelle B, Ferrés MG. Hantavirus prevalence in the IX Region of Chile. Emerg Infect Dis. 2003;9:827-32.
31. Armien B, Pascale JM, Munoz C, Lee S-J, Choi KL, Avila M, et al. Incidence rate for hantavirus infections without pulmonary syndrome, Panama. Emerg Infect Dis [Internet]. 2011 Oct [cited 2013 Oct 13];17(10):1936-9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3310655&tool=pmcentrez&rendertype=abstract.
32. Ferrer JF, Jonsson CB, Esteban E, Galligan D, Basombrio M a, Peralta-Ramos M, et al. High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg [Internet]. 1998 Sep;59(3):438-44. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/9749641.
33. Williams RJ, Bryan RT, Mills JN, Palma RE, Vera I, De Velasquez F, et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg [Internet]. 1997 Sep [cited 2013 Oct 13];57(3):274-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9311636.
34. Mertens M, Hofmann J, Petraityte-Burneikiene R, Ziller M, Sasnauskas K, Friedrich R, et al. Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses. Med. Microbiol. Immunol. 2011;200(4):263-8.
35. Schultze D, Fierz W, Matter HC, Bankoul S, Niedrig M, Schmiedl A. Cross-sectional survey on hantavirus seroprevalence in Canton St. Gallen, Switzerland. Swiss Med Wkly Off J Swiss Soc Infect Dis Swiss Soc Intern Med Swiss Soc Pneumol. 2007;137:21-6. (Pubitemid 46191227)
36. Fontana-Binard L, Schultze D, Rojanavisut BS, Krüger DH, Dollenmaier G, Zanetti G, et al. [First case of nephropathia epidemica acquired in Switzerland]. Rev. Med. Suisse. 2008;4(163):1572-5. French.
37. Boone I, Wagner-Wiening C, Reil D, Jacob J, Rosenfeld UM, Ulrich RG, et al. Rise in the number of notified human hantavirus infections since October 2011 in Baden-Wurttemberg, Germany. Euro Surveill [Internet]. 2012 May 24 [cited 2014 Jan 1];17(21). Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 22687824.
38. Lednicky JA. Hantaviruses. a short review. Arch Pathol Lab Med [Internet]. 2003 Jan [cited 2013 Oct 13];127(1):30-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12521363.
39. Hautala N, Kauma H, Rajaniemi S-M, Sironen T, Vapalahti O, Pääkkö E, et al. Signs of general inflammation and kidney function are associated with the ocular features of acute Puumala hantavirus infection. Scand. J. Infect. Dis. 2012;44(12):1-7.
40. Nichol ST. Bunyaviruses. In: Knipe DM, Howley PM, eds. Field's Virol Vol 2, 4th ed Philadelphia, Pa Lippincott Williams Wilkins. 2001. p. 1603-33.
41. Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, Mäkelä S, et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol [Internet]. 2013 Aug [cited 2013 Oct 13];11(8):539-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24020072.
42. Vial PA, Valdivieso F, Mertz G, Castillo C, Belmar E, Delgado I, et al. Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis [Internet]. 2006 Aug [cited 2013 Oct 13];12(8):1271-3. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3291207&tool= pmcentrez&rendertype=abstract.
43. Riquelme R, Riquelme M, Torres A, Rioseco ML, Vergara JA, Scholz L, et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis [Internet]. 2003 Nov [cited 2013 Oct 13];9(11):1438-43. Available from: http://www.ncbi.nlm. nih.gov/pubmed/14718088.
44. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med [Internet]. 1996 Feb [cited 2013 Oct 13];24(2):252-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8605797.
45. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med [Internet]. 1994 Apr 7 [cited 2013 Oct 13];330(14):949-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8121458.
46. Campos GM, Borges AA, Badra SJ, Figueiredo GG, Souza RLM de, Moreli ML, et al. [Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil]. Rev Soc Bras Med Trop [Internet]. 2009 [cited 2013 Oct 13];42(3):282-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19684976.
47. Castillo C, Naranjo J, Sepúlveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest [Internet]. 2001 Aug [cited 2013 Oct 13];120(2):548-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11502657.
48. Talamonti L, Padula PJ, Canteli MS, Posner F, Marczeski FP, Weller C. Hantavirus pulmonary syndrome: encephalitis caused by virus Andes. J Neurovirol [Internet]. 2011 Apr [cited 2013 Oct 13];17(2):189-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21240581.
49. Armien B, Pascale JM, Muñoz C, Mariñas J, Núñez H, Herrera M, et al. Hantavirus fever without pulmonary syndrome in Panama. Am J Trop Med Hyg [Internet]. 2013 Sep [cited 2014 Jan 1];89(3):489-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23836565.
50. Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, et al. High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis [Internet]. 2013 Oct [cited 2013 Oct 13];57(7):943-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23784924.
51. Gracia F, Armien B, Simpson SQ, Munoz C, Broce C, Pascale JM, et al. Convalescent pulmonary dysfunction following hantavirus pulmonary syndrome in Panama and the United States. Lung [Internet]. 2010 Oct [cited 2013 Oct 13];188(5):387-91. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2939327&tool=pmcentrez&rendertype=abstract.
52. Feldmann H, Sanchez A, Morzunov S, Spiropoulou CF, Rollin PE, Ksiazek TG, et al. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res [Internet]. 1993 Dec [cited 2013 Oct 13];30(3):351-67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8109165.
53. Elgh F, Lundkvist A, Alexeyev OA, Stenlund H, Avsic-Zupanc T, Hjelle B, et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol [Internet]. 1997 May [cited 2013 Oct 13];35(5):1122-30. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=232715&tool= pmcentrez&rendertype=abstract.
54. Hjelle B, Jenison S, Torrez-Martinez N, Herring B, Quan S, Polito A, et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol [Internet]. 1997 Mar [cited 2013 Oct 13];35(3):600-8. Available from: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=229635&tool=pmcentrez&rendertype=abstract.
55. Schmidt J, Meisel H, Capria SG, Petraityte R, Lundkvist a, Hjelle B, et al. Serological assays for the detection of human Andes hantavirus infections based on its yeast-expressed nucleocapsid protein. Intervirology [Internet]. 2006 Jan [cited 2013 Sep 26];49(3):173-84. Available from: http://www.ncbi.nlm. nih.gov/pubmed/16428893.
56. Lederer S, Lattwein E, Hanke M, Sonnenberg K, Stoecker W, Lundkvist Å, et al. Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Negl Trop Dis [Internet]. 2013 Jan [cited 2013 Oct 13];7(4):e2157. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3617148&tool=pmcentrez&rendertype=abstract.
57. Padula PJ, Rossi CM, Della Valle MO, Martínez P V, Colavecchia SB, Edelstein A, et al. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol [Internet]. 2000 Feb [cited 2013 Oct 13];49(2):149-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10670565
58. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis [Internet]. 1999 Feb [cited 2013 Oct 13];179(2):295-302. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 9878011.
59. Gupta S, Braun M, Tischler ND, Stoltz M, Sundström KB, Björkström NK, et al. Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog [Internet]. 2013 Mar [cited 2013 Oct 13];9(3):e1003272. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3610645&tool=pmcentrez&rendertype=abstract.
60. Koster F, Vigil J, Olson D, Terajima M, Ennis F, Al. E. Am J Trop Med 65: (Abstr.). Cl I, II III HLA alleles Assoc with Sev hantavirus Cardiopulm Syndr southwest US. 2001.
61. Ferrer C P, Vial C PA, Ferrés G M, Godoy M P, Culza V A, Marco C C, et al. Genetic susceptibility to Andes Hantavirus: Association between severity of disease and HLA alíeles in Chilean patients. Rev Chil Infectol organo Of la Soc Chil Infectol [Internet]. 2007;24:351-9. Available from: http://www.scielo.cl/scielo.php?script=sci-arttext&pid=S0716- 10182007000500001&lng=en&nrm=62
62. Manigold T, Mori A, Graumann R, Llop E, Simon V, Ferrés M, et al. Highly Differentiated, Resting Gn-Specific Memory CD8+ T Cells Persist Years after Infection by Andes Hantavirus. PLoS Pathog [Internet]. 2010;6:16. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2824805&tool=pmcentrez&rendertype=abstract.
63. Manigold T, Martinez J, Lazcano X, Ye C, Schwartz S, Cuiza A, et al. Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. [Internet]. J. Med. Virol. 2008. p. 1947-51. Available from: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=18814258.
64. Hammerbeck CD, Hooper JW. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J Virol [Internet]. 2011 Oct [cited 2013 Oct 13];85(19):9929-44. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3196444&tool= pmcentrez&rendertype=abstract.
65. Prescott J, Safronetz D, Haddock E, Robertson S, Scott D, Feldmann H. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster. Immunology [Internet]. 2013 Oct [cited 2013 Oct 13];140(2):168-78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23600567.
66. Matthys V, Mackow ER. Hantavirus regulation of type I interferon responses. Adv Virol [Internet]. 2012 Jan [cited 2013 Oct 13];2012:524024. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3423653&tool=pmcentrez&rendertype=abstract.
67. Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol [Internet]. 2001 Jan [cited 2013 Oct 13];256:91-115. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11217408.
68. Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M. IFN-beta protects from vascular leakage via up-regulation of CD73. Eur J Immunol [Internet]. 2007 Dec [cited 2013 Oct 13];37(12):3334-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18034430.
69. Patkar C, Giaya K, Libraty DH. Dengue virus type 2 modulates endothelial barrier function through CD73. Am J Trop Med Hyg [Internet]. 2013 Jan [cited 2013 Oct 13];88(1):89-94. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3541750&tool=pmcentrez&rendertype=abstract.
70. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol [Internet]. 1999 May [cited 2013 Oct 13];73(5):3951-9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 104173&tool=pmcentrez&rendertype=abstract.
71. Ma Y-Q, Qin J, Plow EF. Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost [Internet]. 2007 Jul [cited 2013 Sep 22];5(7):1345-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17635696.
72. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis [Internet]. 2000 Jul [cited 2013 Oct 13];182(1):43-8. Available from: http://www.ncbi.nlm. nih.gov/pubmed/10882580.
73. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine. 2003;
74. Terajima M, Hendershot JD, Kariwa H, Koster FT, Hjelle B, Goade D, et al. High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis [Internet]. 1999 Dec [cited 2013 Oct 13];180(6):2030-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10558964.
75. Pinschewer DD, Perez M, Jeetendra E, Bächi T, Horvath E, Hengartner H, et al. Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest [Internet]. 2004 Oct [cited 2013 Oct 13];114(7):988-93. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 518669&tool=pmcentrez&rendertype=abstract.
76. Ma Y, Wang J, Yuan B, Wang M, Zhang Y, Xu Z, et al. HLA-A2 and B35 restricted hantaan virus nucleoprotein CD8+ T-cell epitope-specific immune response correlates with milder disease in hemorrhagic fever with renal syndrome. PLoS Negl Trop Dis [Internet]. 2013 Jan [cited 2013 Oct 8];7(2):e2076. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3585118&tool=pmcentrez&rendertype=abstract.
77. Martinez VP, Padula PJ. Induction of Protective Immunity in a Syrian Hamster Model Against a Cytopathogenic Strain of Andes Virus. Cell. 2012;95:87-95.
78. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis [Internet]. 1991 Dec [cited 2013 Oct 13];164(6):1119-27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1683355.
79. Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, et al. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis [Internet]. 2002 Feb 1 [cited 2013 Oct 13];34(3):293-304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11774075.
80. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis [Internet]. 2004 Nov 1 [cited 2013 Oct 13];39(9):1307-13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15494907.
81. Safronetz D, Haddock E, Feldmann F, Ebihara H, Feldmann H. In vitro and in vivo activity of ribavirin against Andes virus infection. PLoS One [Internet]. 2011 Jan [cited 2013 Oct 13];6(8):e23560. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3154477&tool= pmcentrez&rendertype=abstract.
82. Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J Virol [Internet]. 2011 Mar [cited 2013 Oct 13];85(5):2296-303. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3067787&tool= pmcentrez&rendertype=abstract.
83. Vial P et al. Treatment of hantavirus cardiopulmonary syndrome with human immune plasma. Submiss Prep.
84. Hjelle B. Vaccines against hantaviruses. Expert Rev Vaccines [Internet]. 2002 Oct [cited 2013 Oct 13];1(3):373-84. Available from: http://www.ncbi.nlm. nih.gov/pubmed/12901576.
85. Hooper JW, Josleyn M, Ballantyne J, Brocato R. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine [Internet]. 2013 Sep 13 [cited 2013 Oct 13];31(40):4314-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23892100.